Related Experiment Video
Updated: May 3, 2026

07:54
Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
Published on: September 2, 2014
49.2K
TNF-α blockade induces IL-10 expression in human CD4+ T cells
Hayley G Evans1, Urmas Roostalu1, Gina J Walter1
1Centre for Molecular & Cellular Biology of Inflammation (CMCBI), Division of Immunology, Infection and Inflammatory Disease, King's College London, SE1 1UL, UK.
Nature Communications
|February 5, 2014
Summary
Tumor necrosis factor inhibitors (TNFi) increase the anti-inflammatory cytokine IL-10 in CD4+ T cells, including those driving inflammation. This TNFi-induced IL-10 production in Th17 cells involves the transcription factor Aiolos.
Area of Science:
- Immunology
- Molecular Biology
- Inflammation Research
Background:
- Interleukin-17-producing CD4+ T (Th17) cells are key players in inflammatory diseases.
- Understanding how therapies modulate these cells is crucial for disease management.
Purpose of the Study:
- To investigate the effect of TNF inhibitors (TNFi) on CD4+ T cells, particularly Th17 cells.
- To elucidate the molecular mechanisms underlying TNFi-induced changes in these cells.
Main Methods:
- Flow cytometry and gene expression analysis of CD4+ T cells from patients treated with TNFi.
- Investigation of the role of Interleukin-10 (IL-10) and the transcription factor IKZF3 (Aiolos).
Main Results:
- TNFi drugs induce the anti-inflammatory cytokine IL-10 in CD4+ T cells, including Th17 cells.
- This induction is independent of regulatory T cells (Treg) and Foxp3, requires IL-10, and can be reversed by IL-1β.
- TNFi-treated Th17 cells show a distinct gene signature including IL10 and IKZF3, with Aiolos binding to the IL10 locus.
- Aiolos overexpression drives IL-10 production in CD4+ T cells.
Conclusions:
- TNF-α blockade by TNFi induces IL-10 production in CD4+ T cells, including Th17 cells.
- The transcription factor Aiolos plays a significant role in regulating IL-10 expression within CD4+ T cells.
Related Concept Videos
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
T Cell Activation and Clonal Selection
13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K

